林业发展局批准Opdivo Qvantig,一种可注射的癌症药物,定于1月首发。 FDA approves Opdivo Qvantig, an injectable cancer drug, set to debut in January.

食品药品管理局已经批准了 布里斯托尔·迈尔斯·斯奎布的 癌症药物的注射版 Opdivo,叫做Opdivo Qvantig。 The FDA has approved an injectable version of Bristol Myers Squibb's cancer drug, Opdivo, called Opdivo Qvantig. 新的表格对病人比较方便,1月初将以与目前的静脉注射版本相同的价格提供。 This new form is more convenient for patients and will be available in early January at the same price as the current intravenous version. 它被批准用于所有先前核准的成人固态肿瘤用途。 It is approved for all previously approved adult solid tumor uses. 批准基于一项研究,该研究表明注射形式与IV版本在晚期癌患者中同样有效. The approval was based on a study showing the injectable form is as effective as the IV version for advanced kidney cancer patients.